Sato R et al. |
[Problems following antibiotic therapy for eradication of Helicobacter pylori]. |
1998 |
Nippon Naika Gakkai Zasshi |
pmid:9648440
|
Nakamura T et al. |
[Topics on Helicobacter pylori (discussion)]. |
1998 |
Nippon Naika Gakkai Zasshi |
pmid:9648442
|
Parente F et al. |
Effects of Helicobacter pylori eradication on gastric function indices in functional dyspepsia. A prospective controlled study. |
1998 |
Scand. J. Gastroenterol. |
pmid:9648983
|
Moshkowitz M et al. |
One-week triple therapy with omeprazole, clarithromycin, and nitroimidazole for Helicobacter pylori infection in children and adolescents. |
1998 |
Pediatrics |
pmid:9651466
|
Wiedermann BL |
Macrolides: clarithromycin and azithromycin. |
1998 |
Pediatr Rev |
pmid:9654947
|
Klein JO |
Clarithromycin and azithromycin. |
1998 |
Pediatr. Infect. Dis. J. |
pmid:9655546
|
Amsden GW et al. |
Oral cimetidine prolongs clarithromycin absorption. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9660986
|
Spinzi GC et al. |
Comparison of omeprazole and lansoprazole in short-term triple therapy for Helicobacter pylori infection. |
1998 |
Aliment. Pharmacol. Ther. |
pmid:9663722
|
Bazzoli F et al. |
Evaluation of short-term low-dose triple therapy for the eradication of Helicobacter pylori by factorial design in a randomized, double-blind, controlled study. |
1998 |
Aliment. Pharmacol. Ther. |
pmid:9663723
|
Pozzato P et al. |
Ranitidine bismuth citrate plus clarithromycin 7-day regimen is effective in eradicating Helicobacter pylori in patients with duodenal ulcer. |
1998 |
Aliment. Pharmacol. Ther. |
pmid:9663724
|
Goh KL et al. |
Comparison of two 1-week low-dose omeprazole triple therapies--optimal treatment for Helicobacter pylori infection? |
1997 |
Aliment. Pharmacol. Ther. |
pmid:9663838
|
Kolkman JJ et al. |
Ranitidine bismuth citrate with clarithromycin versus omeprazole with amoxycillin in the cure of Helicobacter pylori infection. |
1997 |
Aliment. Pharmacol. Ther. |
pmid:9663840
|
Miyaji H et al. |
Susceptibility of Helicobacter pylori isolates to metronidazole, clarithromycin and amoxycillin in vitro and in clinical treatment in Japan. |
1997 |
Aliment. Pharmacol. Ther. |
pmid:9663841
|
Sanfélix Genovés J et al. |
[Helicobacter pylori: 6-day triple therapy in duodenal ulcer]. |
1998 |
Aten Primaria |
pmid:9670578
|
de Boer WA et al. |
Optimal treatment of Helicobacter pylori with ranitidine bismuth citrate (RBC): a randomized comparison between two 7-day triple therapies and a 14-day dual therapy. |
1998 |
Am. J. Gastroenterol. |
pmid:9672338
|
Dore MP et al. |
Demonstration of unexpected antibiotic resistance of genotypically identical Helicobacter pylori isolates. |
1998 |
Clin. Infect. Dis. |
pmid:9675458
|
Dunne EF et al. |
Streptomyces pneumonia in a patient with human immunodeficiency virus infection: case report and review of the literature on invasive streptomyces infections. |
1998 |
Clin. Infect. Dis. |
pmid:9675460
|
Perri F et al. |
Relationship between the results of pre-treatment urea breath test and efficacy of eradication of Helicobacter pylori infection. |
1998 |
Ital J Gastroenterol Hepatol |
pmid:9675647
|
Talley NJ et al. |
Nizatidine in combination with amoxycillin and clarithromycin in the treatment of Helicobacter pylori infection. |
1998 |
Aliment. Pharmacol. Ther. |
pmid:9678811
|
Ricciardiello L et al. |
Efficacy and safety of three 7-day Helicobacter pylori eradication regimens containing ranitidine bismuth citrate. |
1998 |
Aliment. Pharmacol. Ther. |
pmid:9678812
|
Cammarota G et al. |
One-week therapy for Helicobacter pylori eradication: ranitidine bismuth citrate plus medium-dose clarithromycin and either tinidazole or amoxycillin. |
1998 |
Aliment. Pharmacol. Ther. |
pmid:9678813
|
Louw JA et al. |
Two-week course of pantoprazole combined with 1 week of amoxycillin and clarithromycin is effective in Helicobacter pylori eradication and duodenal ulcer healing. |
1998 |
Aliment. Pharmacol. Ther. |
pmid:9678814
|
Ahuja V et al. |
Lansoprazole and secnidazole with clarithromycin, amoxycillin or pefloxacin in the eradication of Helicobacter pylori in a developing country. |
1998 |
Aliment. Pharmacol. Ther. |
pmid:9678815
|
Grübel P and Cave DR |
Factors affecting solubility and penetration of clarithromycin through gastric mucus. |
1998 |
Aliment. Pharmacol. Ther. |
pmid:9678818
|
Tonai A et al. |
[Clarithromycin suppression of DNA synthesis by rat nasal mucosal cells enhanced by endotoxin instillation]. |
1997 |
Jpn J Antibiot |
pmid:9678983
|
Bordet AL et al. |
[Mycobacterium chelonae cutaneous infection: efficacy of prolonged treatment by clarithromycin]. |
1997 |
Ann Dermatol Venereol |
pmid:9686059
|
Martin SJ and Pendland SL |
Bactericidal activity and postantibiotic effect of clarithromycin and 14-hydroxyclarithromycin, alone and in combination, against Legionella pneumophila. |
1998 |
J. Antimicrob. Chemother. |
pmid:9687103
|
Portaels F et al. |
In vitro susceptibility of Mycobacterium ulcerans to clarithromycin. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9687409
|
Bigard MA et al. |
One-week triple therapy using omeprazole, amoxycillin and clarithromycin for the eradication of Helicobacter pylori in patients with non-ulcer dyspepsia: influence of dosage of omeprazole and clarithromycin. |
1998 |
Aliment. Pharmacol. Ther. |
pmid:9690730
|
Soepandi P et al. |
The pattern of micro-organisms and the efficacy of new macrolide in acute lower respiratory tract infections. |
1998 |
Respirology |
pmid:9692520
|
Bardhan KD et al. |
Pantoprazole-based 10-day triple therapy is effective in Helicobacter pylori eradication. |
1998 |
Aliment. Pharmacol. Ther. |
pmid:9692693
|
Catalano F et al. |
Ranitidine bismuth citrate versus omeprazole triple therapy for the eradication of Helicobacter pylori and healing of duodenal ulcer. |
1998 |
Aliment. Pharmacol. Ther. |
pmid:9692702
|
Dobrilla G et al. |
Ranitidine bismuth citrate with either clarithromycin 1 g/day or 1.5 g/day is equally effective in the eradication of H. pylori and healing of duodenal ulcer. |
1998 |
Aliment. Pharmacol. Ther. |
pmid:9692703
|
Habu Y et al. |
Triple therapy with omeprazole, amoxicillin and clarithromycin is effective against Helicobacter pylori infection in gastric ulcer patients as well as in duodenal ulcer patients. Results of a randomized controlled trial in Japan. |
1998 Jul-Aug |
Digestion |
pmid:9693202
|
Hashimoto Y |
[Eradication therapies for Helicobacter pylori]. |
1998 |
Kansenshogaku Zasshi |
pmid:9695480
|
Wakasugi H et al. |
Effect of clarithromycin on renal excretion of digoxin: interaction with P-glycoprotein. |
1998 |
Clin. Pharmacol. Ther. |
pmid:9695727
|
Hsieh PF et al. |
Molecular mechanisms of clarithromycin resistance in Helicobacter pylori. |
1998 |
J. Formos. Med. Assoc. |
pmid:9700240
|
Fennerty MB et al. |
A comparison of 10 and 14 days of lansoprazole triple therapy for eradication of Helicobacter pylori. |
1998 Aug 10-24 |
Arch. Intern. Med. |
pmid:9701099
|
Takizawa H et al. |
Erythromycin and clarithromycin attenuate cytokine-induced endothelin-1 expression in human bronchial epithelial cells. |
1998 |
Eur. Respir. J. |
pmid:9701415
|
Ellenrieder V et al. |
Influence of clarithromycin dosage on pantoprazole combined triple therapy for eradication of Helicobacter pylori. |
1998 |
Aliment. Pharmacol. Ther. |
pmid:9701524
|
Wang G et al. |
Genotypic characterization of clarithromycin-resistant and -susceptible Helicobacter pylori strains from the same patient demonstrates existence of two unrelated isolates. |
1998 |
J. Clin. Microbiol. |
pmid:9705423
|
van der Wouden EJ et al. |
One-week triple therapy with ranitidine bismuth citrate, clarithromycin and metronidazole versus two-week dual therapy with ranitidine bismuth citrate and clarithromycin for Helicobacter pylori infection: a randomized, clinical trial. |
1998 |
Am. J. Gastroenterol. |
pmid:9707042
|
Burman WJ et al. |
Long-term outcomes of treatment of Mycobacterium avium complex bacteremia using a clarithromycin-containing regimen. |
1998 |
AIDS |
pmid:9708410
|
Fernández Bermejo M and GarcÃa Grávalos R |
[Ebrotidine in the eradicating treatment of H. pylori]. |
1998 Jun-Jul |
Gastroenterol Hepatol |
pmid:9711019
|
Bergmann JS and Woods GL |
In vitro activity of antimicrobial combinations against clinical isolates of susceptible and resistant Mycobacterium tuberculosis. |
1998 |
Int. J. Tuberc. Lung Dis. |
pmid:9712275
|
Améndola R et al. |
[Is dental plaque a normal Helicobacter pylori reservoir?]. |
1998 |
Acta Gastroenterol. Latinoam. |
pmid:9713656
|
Cecchi R and Torelli E |
Schönlein-Henoch purpura in association with duodenal ulcer and gastric Helicobacter pylori infection. |
1998 |
J. Dermatol. |
pmid:9714985
|
Tanahashi T et al. |
Analysis of the 13C-urea breath test for detection of Helicobacter pylori infection based on the kinetics of delta-13CO2 using laser spectroscopy. |
1998 |
J. Gastroenterol. Hepatol. |
pmid:9715426
|
Venuta A et al. |
Azithromycin compared with clarithromycin for the treatment of streptococcal pharyngitis in children. |
1998 Jun-Jul |
J. Int. Med. Res. |
pmid:9718470
|
Nelson KG et al. |
Results of operation in Mycobacterium avium-intracellulare lung disease. |
1998 |
Ann. Thorac. Surg. |
pmid:9725364
|